
Dr. Kristin Rojas has received a $375,000 grant from the National Cancer Institute’s Early-Stage Surgeon Scientist Program to study how perioperative opioids may influence breast cancer progression through the gut microbiome.
Building on previous research by Dr. Sabita Roy, which links opioids to gut microbiome disruption and systemic inflammation, Dr. Rojas aims to explore whether these changes adversely affect hormone-sensitive breast cancer. The study leverages a unique patient division—those receiving more vs. fewer surgical opioids—to examine potential effects on cancer outcomes.
With additional training support and collaboration with Dr. Roy and Dr. Nipun Merchant, Dr. Rojas hopes this project will provide crucial data to inform future NIH grants and lead to interventions preventing opioid-induced cancer risks.